Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Diego Pizzagalli, Ph.D.

Co-Author

This page shows the publications co-authored by Diego Pizzagalli and Maurizio Fava.
Connection Strength

3.013
  1. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry. 2009 Jun; 166(6):702-10.
    View in: PubMed
    Score: 0.407
  2. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res. 2008 Nov; 43(1):76-87.
    View in: PubMed
    Score: 0.379
  3. A multi-pronged investigation of option generation using depression, PET and modafinil. Brain. 2022 Feb 12.
    View in: PubMed
    Score: 0.247
  4. Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychol Med. 2020 Nov 20; 1-9.
    View in: PubMed
    Score: 0.226
  5. Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse. Biol Psychiatry. 2020 10 15; 88(8):657-667.
    View in: PubMed
    Score: 0.218
  6. Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial. Biol Psychiatry. 2019 05 15; 85(10):872-880.
    View in: PubMed
    Score: 0.198
  7. Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study. Psychol Med. 2019 05; 49(7):1118-1127.
    View in: PubMed
    Score: 0.192
  8. Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2018 06 01; 75(6):547-554.
    View in: PubMed
    Score: 0.191
  9. Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study. Neuropsychopharmacology. 2016 Jan; 41(2):454-63.
    View in: PubMed
    Score: 0.155
  10. A computational analysis of flanker interference in depression. Psychol Med. 2015 Aug; 45(11):2333-44.
    View in: PubMed
    Score: 0.152
  11. Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biol Psychiatry. 2015 Feb 01; 77(3):285-294.
    View in: PubMed
    Score: 0.145
  12. Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties. Psychol Med. 2015 Jan; 45(1):121-31.
    View in: PubMed
    Score: 0.144
  13. Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study. J Nerv Ment Dis. 2011 Oct; 199(10):807-10.
    View in: PubMed
    Score: 0.120
  14. Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study. J Nerv Ment Dis. 2007 Sep; 195(9):729-37.
    View in: PubMed
    Score: 0.091
  15. PET imaging of neurotransmission using direct parametric reconstruction. Neuroimage. 2020 11 01; 221:117154.
    View in: PubMed
    Score: 0.055
  16. Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive Disorder. Neuropsychopharmacology. 2015 Jul; 40(8):1940-6.
    View in: PubMed
    Score: 0.038
  17. Neural substrates of attentional bias for smoking-related cues: an FMRI study. Neuropsychopharmacology. 2010 Nov; 35(12):2339-45.
    View in: PubMed
    Score: 0.028
  18. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010 Apr 15; 67(8):722-9.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.